Allegra Medical Technologies Limited

As of June 30, 2023, Allegra Medical Technologies Limited has 104.46M shares outstanding.

These figures are as of June 30, 2023.

These figures are as of June 30, 2023. Allegra Medical Technologies Limited trades at an EV/FCF ratio of 26.91, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2023, Allegra Medical Technologies Limited maintains a current ratio of 1.28, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -208.62, indicating conservative leverage, while an interest coverage ratio of -9.93 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2023. Return on assets (ROA) is negative at -85.61, reflecting losses generated across the asset base. Inventory turnover of 0.01 indicates how many times Allegra Medical Technologies Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on February 27, 2024, Allegra Medical Technologies Limited's stock has declined approximately 47.27% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.05.

These figures cover the twelve months ended June 30, 2023. Free cash flow yield stands at 0.58, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -7.54, meaning Allegra Medical Technologies Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Allegra Medical Technologies Limited's most recent stock split took place on March 15, 2017 with a 1000:1067 split ratio.

As of June 30, 2023, Allegra Medical Technologies Limited has an Altman Z-Score of -12.74, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.